Company Search:
Advanced Search
Sponsored Links
GlaxoSmithKline plc Company Snapshot
GlaxoSmithKline plc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other pharmaceutical manufacturers in Europe: Sanofi S.A. of France (2016 sales of 34.71 billion Euro [US$40.74 billion] of which 84% was Pharmaceuticals), Roche Holding Aktiengesellschaft of Switzerland (50.58 billion Swiss Francs [US$51.04 billion] of which 77% was Pharmaceuticals), and Novartis AG which is also based in Switzerland (48.83 billion Swiss Francs [US$49.27 billion] of which 66% was Innovative Medicines).

Sales Analysis. During the year ended December of 2016, sales at GlaxoSmithKline plc were £27.89 billion (US$36.94 billion). This is an increase of 16.6% versus 2015, when the company's sales were £23.92 billion. The sales level in 2016 was fairly close to the level five years ago: in 2011, GlaxoSmithKline plc had sales of £27.39 billion. Sales of Vaccines saw an increase of 25.6% in 2016, from £3.66 billion to £4.59 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
GlaxoSmithKline plc
  Stock Performance Chart for GlaxoSmithKline plc
  Stock Data: Recent Stock Performance:
  Current Price (11/17/2017): 1,308.00p
(Figures in Pounds Sterling)
1 Week -0.8%   13 Weeks -14.1%  
4 Weeks -12.2%   52 Weeks -14.1%  
GlaxoSmithKline plc Key Data:
  Ticker: GSK Country: United Kingdom
  Exchanges: DUS FRA LON OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 27,889,000,000
(Year Ending Jan 2017).
Employees: 99,827
  Currency: Pounds Sterling Market Cap: 64,335,695,704
  Fiscal Yr Ends: December Shares Outstanding: 4,918,631,170
  Share Type: Ordinary Closely Held Shares: 56,418,439
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.